Top Stories
-
Established two decades ago, the essential tremor brain bank at Columbia has been instrumental in revealing the source and biology of a common but understudied neurodegenerative disorder.
Topic
-
Variants of the ABCA7 gene accelerate neurodegeneration by reducing the amount of neuropeptide Y, a protein essential for maintaining brain synapses.
Topic
-
Analysis of 1.6 million brain cells from older adults has captured the cellular changes that occur in Alzheimer’s early stages, revealing potential new targets and routes for prevention.
Topic
-
An international study shows as many as one-quarter of unresponsive patients with brain injuries have some level of awareness, a finding that could spur development of new treatments.
Topic
Latest News
- August 9, 2013
Watch all eight talks from TEDMED Day CUMC, now available online.
Topic
- July 24, 2013
Key molecular pathways that lead to Alzheimer's identified—a new approach to Alzheimer’s research; several potential drug targets highlighted.
Topic
- July 11, 2013
In an article in Scientific American’s “Talking Back Blog” published yesterday, writer Gary Stix highlights the work of Columbia’s Dr. Olajide Williams.
Topic
- June 27, 2013
Ottavio Arancio, MD, PhD, of CUMC's Taub Institute, coauthored a paper on a compound that prevents memory loss in a mouse model of Alzheimer's. See Northwestern's news release: http://bit.ly/14Zqwwn
Topic
- June 25, 2013
Mouse study suggests inhibiting protein called caspase-2 might prevent cognitive decline in Alzheimer's
Topic
- June 19, 2013
One in 4 stroke survivors suffer from PTSD symptoms within the 1st year post-event, and 1 in 9 experience chronic PTSD more than a year later - results of a study led by Columbia University Medical Center researchers.
Topic
- May 6, 2013
Columbia University study looks at the relationship between families with exceptional longevity and cognitive impairment consistent with Alzheimer's disease.
Topic
- May 1, 2013
Four research centers including the Center for Stroke Disparities Solutions—a partnership of the New York University Langone Medical Center and Columbia University Medical Center —will develop high-impact culturally tailored interventions aimed at lowering stroke risk among racial and ethnic minorities in the United States.
Topic
- April 17, 2013
Excess glutamate in the brain may spur psychosis in those at risk for schizophrenia, report CUMC investigators in a study published in Neuron.
Topic
-
Source:
Alzheimer Research ForumApril 10, 2013African-Americans carrying a variant in a cholesterol-processing gene, ABCA7, have double the risk for Alzheimer’s than non-carriers. A new study led by CUMC's Richard Mayeux; first author Christiane Reitz.
Topic
